We previously demonstrated that p53 conformational alterations were found in different cell types derived from AD patients (fibroblasts, immortalized B lymphocytes, and peripheral blood mononuclear cells (PBMCs)) as well as in in vitro and in vivo models [11,12], using several experimental approaches. The gene discussed is TP53; the disease is Alzheimer disease.